TABLE 1.

Clinical characteristics of study participants

Cohort	No. of patients	Plasma VLa		CD4 T cell count (no. of cells/μl)		ART
		Median	Range	Median	Range
PHI	17	10,841	1,531-15,300,000	521	164-964	Yesb
EC	7	<50	<50	769	368-1,741	No
VC	8	236	63-847	985	722-1,620	No
P	11	86,900	18,501-484,600	514	334-874	No

^aViral load (VL) is shown as the number of HIV-1 RNA copies/ml at the time of sample collection.

^bA total of 11/17 patients were on antiretroviral therapy (ART) for 2 to 4 weeks.